Daxor Corporation

DXR | NASDAQ

Price Alert Chart Builder DCF Calculator

$9.20

+$0.28 (+3.14%)

At close: Oct 30, 2026, 4:00 PM ET

$8.92

-$0.28 (-3.04%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.14%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

61.5

+3.0 pts

Fundamentals Strong

Market Sentiment Neutral

Moat Narrow

Sector Rank #119/1028 (Top 12%)

Full Analysis

Key Statistics

Market Data

Market Cap $53.71M

1D Range

8.40 9.30

52W Range

8.40 14.75

Valuation (TTM)

PE 7.48

PB 1.04

EV/EBITDA 7.69

Valuation (NTM)

Forward PE 60.78

Forward PEG 0.02

Price Target $23.00

Cash Flow

FCF Yield -5.2%

SBC Adj. FCF Yield -5.2%

SBC Impact N/A

Margins

Gross Margin -106.5%

Operating Margin 4024.1%

FCF Margin -1811.4%

Growth (CAGR)

Revenue 3Y | 5Y -20.3% | -25.4%

Dil EPS 3Y | 5Y 46.3% | 302.0%

FCF 3Y | 5Y 3.6% | -25.2%

Returns

ROA 12.0%

ROE 12.8%

ROIC 12.0%

Financial Health

Net Cash

$5.79M

Current Ratio 0.00

Interest Coverage 1,862.49

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blo...

Sector Healthcare

Industry Medical - Instruments & Supplies

Employees 37

IPO Date Jul 25, 1983

Website www.daxor.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.